Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
HC Wainwright & Co. Maintains Buy on Apellis Pharmaceuticals, Lowers Price Target to $83
Magnificent 7 Lose Over $300B As Volatility Index Surges, Traders Question Fed's Timing
Vertex Boosts Revenue Forecast on Back of Cystic Fibrosis Franchise Growth
Apellis Pharmaceuticals Analyst Ratings
LabCorp's Stock Soars After Q2 Performance, Analyst Highlights Strong Position In Healthcare Sector
REGENXBIO Releases New Data on DMD Drug Ahead of Earnings